Hexagon Capital Partners’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-1,730
Closed -$23.4K – 325
2025
Q1
$23.4K Buy
1,730
+394
+29% +$6.54K ﹤0.01% 705
2024
Q4
$22.6K Buy
1,336
+499
+60% +$9.71K ﹤0.01% 747
2024
Q3
$17K Buy
837
+230
+38% +$4.7K ﹤0.01% 772
2024
Q2
$13.7K Buy
607
+9
+2% +$236 ﹤0.01% 790
2024
Q1
$15.7K Sell
598
-196
-25% -$5.58K ﹤0.01% 744
2023
Q4
$25K Buy
+794
New +$21.5K 0.01% 569
2023
Q1
– Sell
-11
Closed -$337 – 1458
2022
Q4
$337 Hold
11
– – ﹤0.01% 1345
2022
Q3
$0 Sell
11
-14
-56% -$462 ﹤0.01% 1309
2022
Q2
$1K Buy
25
+14
+127% +$515 ﹤0.01% 1035
2022
Q1
$0 Buy
+11
New +$344 ﹤0.01% 925

Other funds holding CC

Hexagon Capital Partners's CC Position: Q2 2025 in Review

Hexagon Capital Partners sold out of Chemours (CC) in Q2 2025, closing a stake of 1,730 shares — an estimated $23.4K sold.

Hexagon Capital Partners first reported a position in CC in Q1 2022 and held it in 10 quarters. The position peaked at $25K in Q4 2023. 434 funds tracked by Wall St. Rank hold CC as of Q2 2025.

  • Hexagon Capital Partners reported no remaining Chemours position as of Q2 2025 after selling out during the quarter.
  • Hexagon Capital Partners sold 1,730 Chemours shares in Q2 2025, an estimated $23.4K.
  • Hexagon Capital Partners first reported a position in Chemours in Q1 2022 and held it in 10 quarters.
  • Hexagon Capital Partners's Chemours position peaked at $25K in Q4 2023.
  • 434 funds tracked by Wall St. Rank held Chemours as of Q2 2025.

Based on Hexagon Capital Partners's 13F filing for Q2 2025, filed 11 Aug 2025.